nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCC3—Ezetimibe—atherosclerosis	0.127	0.185	CbGbCtD
Omeprazole—ABCG2—Ezetimibe—atherosclerosis	0.052	0.0759	CbGbCtD
Omeprazole—ABCG2—Rosuvastatin—atherosclerosis	0.052	0.0759	CbGbCtD
Omeprazole—ABCG2—Pravastatin—atherosclerosis	0.0473	0.069	CbGbCtD
Omeprazole—CYP2C8—Simvastatin—atherosclerosis	0.0258	0.0376	CbGbCtD
Omeprazole—CYP2C8—Pravastatin—atherosclerosis	0.0252	0.0368	CbGbCtD
Omeprazole—CYP2C8—Lovastatin—atherosclerosis	0.0252	0.0368	CbGbCtD
Omeprazole—CYP2C19—Rosuvastatin—atherosclerosis	0.0233	0.0339	CbGbCtD
Omeprazole—CYP2C19—Simvastatin—atherosclerosis	0.0216	0.0315	CbGbCtD
Omeprazole—CYP2C19—Lovastatin—atherosclerosis	0.0212	0.0308	CbGbCtD
Omeprazole—CYP2D6—Niacin—atherosclerosis	0.0208	0.0303	CbGbCtD
Omeprazole—CYP2C9—Rosuvastatin—atherosclerosis	0.0193	0.0282	CbGbCtD
Omeprazole—ABCB1—Ezetimibe—atherosclerosis	0.0188	0.0274	CbGbCtD
Omeprazole—CYP2C9—Simvastatin—atherosclerosis	0.018	0.0262	CbGbCtD
Omeprazole—CYP2C9—Lovastatin—atherosclerosis	0.0176	0.0256	CbGbCtD
Omeprazole—CYP2C9—Pravastatin—atherosclerosis	0.0176	0.0256	CbGbCtD
Omeprazole—ABCB1—Simvastatin—atherosclerosis	0.0174	0.0254	CbGbCtD
Omeprazole—ABCB1—Lovastatin—atherosclerosis	0.0171	0.0249	CbGbCtD
Omeprazole—ABCB1—Pravastatin—atherosclerosis	0.0171	0.0249	CbGbCtD
Omeprazole—CYP2D6—Simvastatin—atherosclerosis	0.0164	0.024	CbGbCtD
Omeprazole—CYP2D6—Lovastatin—atherosclerosis	0.0161	0.0234	CbGbCtD
Omeprazole—CYP2D6—Pravastatin—atherosclerosis	0.0161	0.0234	CbGbCtD
Omeprazole—CYP3A4—Ezetimibe—atherosclerosis	0.0112	0.0164	CbGbCtD
Omeprazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0112	0.0164	CbGbCtD
Omeprazole—CYP3A4—Simvastatin—atherosclerosis	0.0105	0.0152	CbGbCtD
Omeprazole—CYP3A4—Pravastatin—atherosclerosis	0.0102	0.0149	CbGbCtD
Omeprazole—CYP3A4—Lovastatin—atherosclerosis	0.0102	0.0149	CbGbCtD
Omeprazole—Tinnitus—Niacin—atherosclerosis	0.000288	0.00137	CcSEcCtD
Omeprazole—Erythema multiforme—Pravastatin—atherosclerosis	0.000288	0.00137	CcSEcCtD
Omeprazole—Dysgeusia—Simvastatin—atherosclerosis	0.000287	0.00136	CcSEcCtD
Omeprazole—Flushing—Niacin—atherosclerosis	0.000287	0.00136	CcSEcCtD
Omeprazole—Angioedema—Lovastatin—atherosclerosis	0.000286	0.00136	CcSEcCtD
Omeprazole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000285	0.00135	CcSEcCtD
Omeprazole—Anaemia—Ezetimibe—atherosclerosis	0.000284	0.00135	CcSEcCtD
Omeprazole—Tinnitus—Pravastatin—atherosclerosis	0.000284	0.00135	CcSEcCtD
Omeprazole—Malaise—Lovastatin—atherosclerosis	0.000283	0.00134	CcSEcCtD
Omeprazole—Flushing—Pravastatin—atherosclerosis	0.000283	0.00134	CcSEcCtD
Omeprazole—Muscle spasms—Simvastatin—atherosclerosis	0.000282	0.00134	CcSEcCtD
Omeprazole—Vertigo—Lovastatin—atherosclerosis	0.000282	0.00134	CcSEcCtD
Omeprazole—Angioedema—Ezetimibe—atherosclerosis	0.000281	0.00133	CcSEcCtD
Omeprazole—Leukopenia—Lovastatin—atherosclerosis	0.000281	0.00133	CcSEcCtD
Omeprazole—Chills—Niacin—atherosclerosis	0.000277	0.00132	CcSEcCtD
Omeprazole—Malaise—Ezetimibe—atherosclerosis	0.000277	0.00131	CcSEcCtD
Omeprazole—Vision blurred—Simvastatin—atherosclerosis	0.000276	0.00131	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000275	0.0013	CcSEcCtD
Omeprazole—Tremor—Simvastatin—atherosclerosis	0.000275	0.0013	CcSEcCtD
Omeprazole—Alopecia—Niacin—atherosclerosis	0.000273	0.0013	CcSEcCtD
Omeprazole—Chills—Pravastatin—atherosclerosis	0.000273	0.0013	CcSEcCtD
Omeprazole—Insomnia—Rosuvastatin—atherosclerosis	0.000273	0.00129	CcSEcCtD
Omeprazole—Ill-defined disorder—Simvastatin—atherosclerosis	0.000272	0.00129	CcSEcCtD
Omeprazole—Palpitations—Ezetimibe—atherosclerosis	0.000272	0.00129	CcSEcCtD
Omeprazole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000271	0.00129	CcSEcCtD
Omeprazole—Anaemia—Simvastatin—atherosclerosis	0.000271	0.00129	CcSEcCtD
Omeprazole—Malnutrition—Niacin—atherosclerosis	0.000269	0.00128	CcSEcCtD
Omeprazole—Alopecia—Pravastatin—atherosclerosis	0.000269	0.00128	CcSEcCtD
Omeprazole—Cough—Ezetimibe—atherosclerosis	0.000268	0.00127	CcSEcCtD
Omeprazole—Angioedema—Simvastatin—atherosclerosis	0.000268	0.00127	CcSEcCtD
Omeprazole—Chest pain—Lovastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Omeprazole—Arthralgia—Lovastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Omeprazole—Myalgia—Lovastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Omeprazole—Anxiety—Lovastatin—atherosclerosis	0.000266	0.00126	CcSEcCtD
Omeprazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000266	0.00126	CcSEcCtD
Omeprazole—Hypertension—Ezetimibe—atherosclerosis	0.000265	0.00126	CcSEcCtD
Omeprazole—Flatulence—Niacin—atherosclerosis	0.000265	0.00126	CcSEcCtD
Omeprazole—Malaise—Simvastatin—atherosclerosis	0.000264	0.00125	CcSEcCtD
Omeprazole—Tension—Niacin—atherosclerosis	0.000264	0.00125	CcSEcCtD
Omeprazole—Discomfort—Lovastatin—atherosclerosis	0.000264	0.00125	CcSEcCtD
Omeprazole—Vertigo—Simvastatin—atherosclerosis	0.000263	0.00125	CcSEcCtD
Omeprazole—Leukopenia—Simvastatin—atherosclerosis	0.000262	0.00124	CcSEcCtD
Omeprazole—Myalgia—Ezetimibe—atherosclerosis	0.000262	0.00124	CcSEcCtD
Omeprazole—Arthralgia—Ezetimibe—atherosclerosis	0.000262	0.00124	CcSEcCtD
Omeprazole—Chest pain—Ezetimibe—atherosclerosis	0.000262	0.00124	CcSEcCtD
Omeprazole—Nervousness—Niacin—atherosclerosis	0.000261	0.00124	CcSEcCtD
Omeprazole—Flatulence—Pravastatin—atherosclerosis	0.000261	0.00124	CcSEcCtD
Omeprazole—Dry mouth—Lovastatin—atherosclerosis	0.000261	0.00124	CcSEcCtD
Omeprazole—Tension—Pravastatin—atherosclerosis	0.00026	0.00123	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00026	0.00123	CcSEcCtD
Omeprazole—Dysgeusia—Pravastatin—atherosclerosis	0.00026	0.00123	CcSEcCtD
Omeprazole—Muscle spasms—Niacin—atherosclerosis	0.000259	0.00123	CcSEcCtD
Omeprazole—Discomfort—Ezetimibe—atherosclerosis	0.000259	0.00123	CcSEcCtD
Omeprazole—Constipation—Rosuvastatin—atherosclerosis	0.000258	0.00122	CcSEcCtD
Omeprazole—Pain—Rosuvastatin—atherosclerosis	0.000258	0.00122	CcSEcCtD
Omeprazole—Confusional state—Lovastatin—atherosclerosis	0.000258	0.00122	CcSEcCtD
Omeprazole—Nervousness—Pravastatin—atherosclerosis	0.000257	0.00122	CcSEcCtD
Omeprazole—Dry mouth—Ezetimibe—atherosclerosis	0.000256	0.00121	CcSEcCtD
Omeprazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000256	0.00121	CcSEcCtD
Omeprazole—Muscle spasms—Pravastatin—atherosclerosis	0.000255	0.00121	CcSEcCtD
Omeprazole—Infection—Lovastatin—atherosclerosis	0.000254	0.00121	CcSEcCtD
Omeprazole—Vision blurred—Niacin—atherosclerosis	0.000254	0.0012	CcSEcCtD
Omeprazole—Confusional state—Ezetimibe—atherosclerosis	0.000253	0.0012	CcSEcCtD
Omeprazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000251	0.00119	CcSEcCtD
Omeprazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.00025	0.00119	CcSEcCtD
Omeprazole—Vision blurred—Pravastatin—atherosclerosis	0.00025	0.00118	CcSEcCtD
Omeprazole—Chest pain—Simvastatin—atherosclerosis	0.00025	0.00118	CcSEcCtD
Omeprazole—Myalgia—Simvastatin—atherosclerosis	0.00025	0.00118	CcSEcCtD
Omeprazole—Arthralgia—Simvastatin—atherosclerosis	0.00025	0.00118	CcSEcCtD
Omeprazole—Infection—Ezetimibe—atherosclerosis	0.000249	0.00118	CcSEcCtD
Omeprazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000249	0.00118	CcSEcCtD
Omeprazole—Anxiety—Simvastatin—atherosclerosis	0.000249	0.00118	CcSEcCtD
Omeprazole—Tremor—Pravastatin—atherosclerosis	0.000248	0.00118	CcSEcCtD
Omeprazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000247	0.00117	CcSEcCtD
Omeprazole—Discomfort—Simvastatin—atherosclerosis	0.000247	0.00117	CcSEcCtD
Omeprazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000246	0.00117	CcSEcCtD
Omeprazole—Angioedema—Niacin—atherosclerosis	0.000246	0.00117	CcSEcCtD
Omeprazole—Ill-defined disorder—Pravastatin—atherosclerosis	0.000246	0.00117	CcSEcCtD
Omeprazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000246	0.00116	CcSEcCtD
Omeprazole—Anaemia—Pravastatin—atherosclerosis	0.000245	0.00116	CcSEcCtD
Omeprazole—Anorexia—Lovastatin—atherosclerosis	0.000244	0.00116	CcSEcCtD
Omeprazole—Skin disorder—Ezetimibe—atherosclerosis	0.000244	0.00116	CcSEcCtD
Omeprazole—Angioedema—Pravastatin—atherosclerosis	0.000242	0.00115	CcSEcCtD
Omeprazole—Vertigo—Niacin—atherosclerosis	0.000242	0.00115	CcSEcCtD
Omeprazole—Confusional state—Simvastatin—atherosclerosis	0.000241	0.00114	CcSEcCtD
Omeprazole—Leukopenia—Niacin—atherosclerosis	0.000241	0.00114	CcSEcCtD
Omeprazole—Urticaria—Rosuvastatin—atherosclerosis	0.00024	0.00114	CcSEcCtD
Omeprazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000239	0.00113	CcSEcCtD
Omeprazole—Malaise—Pravastatin—atherosclerosis	0.000239	0.00113	CcSEcCtD
Omeprazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000239	0.00113	CcSEcCtD
Omeprazole—Vertigo—Pravastatin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Omeprazole—Palpitations—Niacin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Omeprazole—Infection—Simvastatin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Omeprazole—Leukopenia—Pravastatin—atherosclerosis	0.000237	0.00113	CcSEcCtD
Omeprazole—Cough—Niacin—atherosclerosis	0.000235	0.00111	CcSEcCtD
Omeprazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.000234	0.00111	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000233	0.00111	CcSEcCtD
Omeprazole—Insomnia—Lovastatin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Omeprazole—Cough—Pravastatin—atherosclerosis	0.000231	0.0011	CcSEcCtD
Omeprazole—Paraesthesia—Lovastatin—atherosclerosis	0.00023	0.00109	CcSEcCtD
Omeprazole—Arthralgia—Niacin—atherosclerosis	0.000229	0.00109	CcSEcCtD
Omeprazole—Myalgia—Niacin—atherosclerosis	0.000229	0.00109	CcSEcCtD
Omeprazole—Hypertension—Pravastatin—atherosclerosis	0.000229	0.00109	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000229	0.00108	CcSEcCtD
Omeprazole—Anorexia—Simvastatin—atherosclerosis	0.000228	0.00108	CcSEcCtD
Omeprazole—Dyspnoea—Lovastatin—atherosclerosis	0.000228	0.00108	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000228	0.00108	CcSEcCtD
Omeprazole—Insomnia—Ezetimibe—atherosclerosis	0.000227	0.00108	CcSEcCtD
Omeprazole—Chest pain—Pravastatin—atherosclerosis	0.000226	0.00107	CcSEcCtD
Omeprazole—Myalgia—Pravastatin—atherosclerosis	0.000226	0.00107	CcSEcCtD
Omeprazole—Arthralgia—Pravastatin—atherosclerosis	0.000226	0.00107	CcSEcCtD
Omeprazole—Paraesthesia—Ezetimibe—atherosclerosis	0.000225	0.00107	CcSEcCtD
Omeprazole—Dyspepsia—Lovastatin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Omeprazole—Anxiety—Pravastatin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Omeprazole—Dry mouth—Niacin—atherosclerosis	0.000224	0.00106	CcSEcCtD
Omeprazole—Dyspnoea—Ezetimibe—atherosclerosis	0.000224	0.00106	CcSEcCtD
Omeprazole—Discomfort—Pravastatin—atherosclerosis	0.000223	0.00106	CcSEcCtD
Omeprazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000222	0.00105	CcSEcCtD
Omeprazole—Decreased appetite—Lovastatin—atherosclerosis	0.000222	0.00105	CcSEcCtD
Omeprazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000221	0.00105	CcSEcCtD
Omeprazole—Fatigue—Lovastatin—atherosclerosis	0.000221	0.00105	CcSEcCtD
Omeprazole—Anaphylactic shock—Niacin—atherosclerosis	0.00022	0.00104	CcSEcCtD
Omeprazole—Pain—Lovastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Omeprazole—Constipation—Lovastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Omeprazole—Confusional state—Pravastatin—atherosclerosis	0.000218	0.00103	CcSEcCtD
Omeprazole—Decreased appetite—Ezetimibe—atherosclerosis	0.000218	0.00103	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000218	0.00103	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000217	0.00103	CcSEcCtD
Omeprazole—Asthenia—Rosuvastatin—atherosclerosis	0.000217	0.00103	CcSEcCtD
Omeprazole—Insomnia—Simvastatin—atherosclerosis	0.000216	0.00103	CcSEcCtD
Omeprazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000216	0.00103	CcSEcCtD
Omeprazole—Fatigue—Ezetimibe—atherosclerosis	0.000216	0.00103	CcSEcCtD
Omeprazole—Shock—Niacin—atherosclerosis	0.000216	0.00103	CcSEcCtD
Omeprazole—Infection—Pravastatin—atherosclerosis	0.000215	0.00102	CcSEcCtD
Omeprazole—Paraesthesia—Simvastatin—atherosclerosis	0.000215	0.00102	CcSEcCtD
Omeprazole—Constipation—Ezetimibe—atherosclerosis	0.000215	0.00102	CcSEcCtD
Omeprazole—Pain—Ezetimibe—atherosclerosis	0.000215	0.00102	CcSEcCtD
Omeprazole—Tachycardia—Niacin—atherosclerosis	0.000214	0.00102	CcSEcCtD
Omeprazole—Pruritus—Rosuvastatin—atherosclerosis	0.000214	0.00101	CcSEcCtD
Omeprazole—Skin disorder—Niacin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Omeprazole—Dyspnoea—Simvastatin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Omeprazole—Hyperhidrosis—Niacin—atherosclerosis	0.000212	0.00101	CcSEcCtD
Omeprazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000212	0.001	CcSEcCtD
Omeprazole—Feeling abnormal—Lovastatin—atherosclerosis	0.000211	0.001	CcSEcCtD
Omeprazole—Dyspepsia—Simvastatin—atherosclerosis	0.000211	0.000999	CcSEcCtD
Omeprazole—Anorexia—Niacin—atherosclerosis	0.000209	0.000993	CcSEcCtD
Omeprazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000209	0.000992	CcSEcCtD
Omeprazole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000209	0.000992	CcSEcCtD
Omeprazole—Decreased appetite—Simvastatin—atherosclerosis	0.000208	0.000986	CcSEcCtD
Omeprazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000207	0.00098	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000207	0.00098	CcSEcCtD
Omeprazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000206	0.000979	CcSEcCtD
Omeprazole—Fatigue—Simvastatin—atherosclerosis	0.000206	0.000978	CcSEcCtD
Omeprazole—Anorexia—Pravastatin—atherosclerosis	0.000206	0.000978	CcSEcCtD
Omeprazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000205	0.000973	CcSEcCtD
Omeprazole—Pain—Simvastatin—atherosclerosis	0.000205	0.00097	CcSEcCtD
Omeprazole—Constipation—Simvastatin—atherosclerosis	0.000205	0.00097	CcSEcCtD
Omeprazole—Urticaria—Lovastatin—atherosclerosis	0.000203	0.000964	CcSEcCtD
Omeprazole—Body temperature increased—Lovastatin—atherosclerosis	0.000202	0.000959	CcSEcCtD
Omeprazole—Abdominal pain—Lovastatin—atherosclerosis	0.000202	0.000959	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.0002	0.000949	CcSEcCtD
Omeprazole—Dizziness—Rosuvastatin—atherosclerosis	0.0002	0.000947	CcSEcCtD
Omeprazole—Urticaria—Ezetimibe—atherosclerosis	0.000199	0.000945	CcSEcCtD
Omeprazole—Insomnia—Niacin—atherosclerosis	0.000199	0.000942	CcSEcCtD
Omeprazole—Abdominal pain—Ezetimibe—atherosclerosis	0.000198	0.000941	CcSEcCtD
Omeprazole—Body temperature increased—Ezetimibe—atherosclerosis	0.000198	0.000941	CcSEcCtD
Omeprazole—Paraesthesia—Niacin—atherosclerosis	0.000197	0.000936	CcSEcCtD
Omeprazole—Feeling abnormal—Simvastatin—atherosclerosis	0.000197	0.000935	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000197	0.000935	CcSEcCtD
Omeprazole—Dyspnoea—Niacin—atherosclerosis	0.000196	0.000929	CcSEcCtD
Omeprazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000196	0.000928	CcSEcCtD
Omeprazole—Insomnia—Pravastatin—atherosclerosis	0.000196	0.000928	CcSEcCtD
Omeprazole—Somnolence—Niacin—atherosclerosis	0.000195	0.000926	CcSEcCtD
Omeprazole—Paraesthesia—Pravastatin—atherosclerosis	0.000194	0.000921	CcSEcCtD
Omeprazole—Dyspepsia—Niacin—atherosclerosis	0.000193	0.000917	CcSEcCtD
Omeprazole—Dyspnoea—Pravastatin—atherosclerosis	0.000193	0.000915	CcSEcCtD
Omeprazole—Decreased appetite—Niacin—atherosclerosis	0.000191	0.000906	CcSEcCtD
Omeprazole—Dyspepsia—Pravastatin—atherosclerosis	0.00019	0.000903	CcSEcCtD
Omeprazole—Rash—Rosuvastatin—atherosclerosis	0.00019	0.000903	CcSEcCtD
Omeprazole—Dermatitis—Rosuvastatin—atherosclerosis	0.00019	0.000902	CcSEcCtD
Omeprazole—Urticaria—Simvastatin—atherosclerosis	0.00019	0.000901	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Niacin—atherosclerosis	0.00019	0.000899	CcSEcCtD
Omeprazole—Body temperature increased—Simvastatin—atherosclerosis	0.000189	0.000897	CcSEcCtD
Omeprazole—Abdominal pain—Simvastatin—atherosclerosis	0.000189	0.000897	CcSEcCtD
Omeprazole—Headache—Rosuvastatin—atherosclerosis	0.000189	0.000897	CcSEcCtD
Omeprazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000188	0.000894	CcSEcCtD
Omeprazole—Decreased appetite—Pravastatin—atherosclerosis	0.000188	0.000892	CcSEcCtD
Omeprazole—Pain—Niacin—atherosclerosis	0.000188	0.000891	CcSEcCtD
Omeprazole—Fatigue—Pravastatin—atherosclerosis	0.000186	0.000884	CcSEcCtD
Omeprazole—Constipation—Pravastatin—atherosclerosis	0.000185	0.000877	CcSEcCtD
Omeprazole—Pain—Pravastatin—atherosclerosis	0.000185	0.000877	CcSEcCtD
Omeprazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000185	0.000877	CcSEcCtD
Omeprazole—Asthenia—Lovastatin—atherosclerosis	0.000184	0.00087	CcSEcCtD
Omeprazole—Pruritus—Lovastatin—atherosclerosis	0.000181	0.000858	CcSEcCtD
Omeprazole—Asthenia—Ezetimibe—atherosclerosis	0.00018	0.000854	CcSEcCtD
Omeprazole—Gastrointestinal pain—Niacin—atherosclerosis	0.00018	0.000852	CcSEcCtD
Omeprazole—Nausea—Rosuvastatin—atherosclerosis	0.000179	0.00085	CcSEcCtD
Omeprazole—Feeling abnormal—Pravastatin—atherosclerosis	0.000178	0.000845	CcSEcCtD
Omeprazole—Pruritus—Ezetimibe—atherosclerosis	0.000177	0.000842	CcSEcCtD
Omeprazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000177	0.000839	CcSEcCtD
Omeprazole—Hypersensitivity—Simvastatin—atherosclerosis	0.000176	0.000836	CcSEcCtD
Omeprazole—Diarrhoea—Lovastatin—atherosclerosis	0.000175	0.00083	CcSEcCtD
Omeprazole—Urticaria—Niacin—atherosclerosis	0.000175	0.000828	CcSEcCtD
Omeprazole—Body temperature increased—Niacin—atherosclerosis	0.000174	0.000824	CcSEcCtD
Omeprazole—Abdominal pain—Niacin—atherosclerosis	0.000174	0.000824	CcSEcCtD
Omeprazole—Urticaria—Pravastatin—atherosclerosis	0.000172	0.000815	CcSEcCtD
Omeprazole—Asthenia—Simvastatin—atherosclerosis	0.000172	0.000814	CcSEcCtD
Omeprazole—Diarrhoea—Ezetimibe—atherosclerosis	0.000172	0.000814	CcSEcCtD
Omeprazole—Body temperature increased—Pravastatin—atherosclerosis	0.000171	0.000811	CcSEcCtD
Omeprazole—Abdominal pain—Pravastatin—atherosclerosis	0.000171	0.000811	CcSEcCtD
Omeprazole—Pruritus—Simvastatin—atherosclerosis	0.000169	0.000803	CcSEcCtD
Omeprazole—Dizziness—Lovastatin—atherosclerosis	0.000169	0.000802	CcSEcCtD
Omeprazole—Dizziness—Ezetimibe—atherosclerosis	0.000166	0.000787	CcSEcCtD
Omeprazole—Diarrhoea—Simvastatin—atherosclerosis	0.000164	0.000776	CcSEcCtD
Omeprazole—Vomiting—Lovastatin—atherosclerosis	0.000163	0.000771	CcSEcCtD
Omeprazole—Hypersensitivity—Niacin—atherosclerosis	0.000162	0.000768	CcSEcCtD
Omeprazole—Rash—Lovastatin—atherosclerosis	0.000161	0.000765	CcSEcCtD
Omeprazole—Dermatitis—Lovastatin—atherosclerosis	0.000161	0.000764	CcSEcCtD
Omeprazole—Headache—Lovastatin—atherosclerosis	0.00016	0.00076	CcSEcCtD
Omeprazole—Vomiting—Ezetimibe—atherosclerosis	0.00016	0.000757	CcSEcCtD
Omeprazole—Hypersensitivity—Pravastatin—atherosclerosis	0.000159	0.000756	CcSEcCtD
Omeprazole—Dizziness—Simvastatin—atherosclerosis	0.000158	0.00075	CcSEcCtD
Omeprazole—Rash—Ezetimibe—atherosclerosis	0.000158	0.00075	CcSEcCtD
Omeprazole—Dermatitis—Ezetimibe—atherosclerosis	0.000158	0.00075	CcSEcCtD
Omeprazole—Asthenia—Niacin—atherosclerosis	0.000158	0.000748	CcSEcCtD
Omeprazole—Headache—Ezetimibe—atherosclerosis	0.000157	0.000745	CcSEcCtD
Omeprazole—Pruritus—Niacin—atherosclerosis	0.000155	0.000737	CcSEcCtD
Omeprazole—Asthenia—Pravastatin—atherosclerosis	0.000155	0.000736	CcSEcCtD
Omeprazole—Pruritus—Pravastatin—atherosclerosis	0.000153	0.000726	CcSEcCtD
Omeprazole—Vomiting—Simvastatin—atherosclerosis	0.000152	0.000721	CcSEcCtD
Omeprazole—Nausea—Lovastatin—atherosclerosis	0.000152	0.000721	CcSEcCtD
Omeprazole—Rash—Simvastatin—atherosclerosis	0.000151	0.000715	CcSEcCtD
Omeprazole—Dermatitis—Simvastatin—atherosclerosis	0.000151	0.000715	CcSEcCtD
Omeprazole—Diarrhoea—Niacin—atherosclerosis	0.00015	0.000713	CcSEcCtD
Omeprazole—Headache—Simvastatin—atherosclerosis	0.00015	0.000711	CcSEcCtD
Omeprazole—Nausea—Ezetimibe—atherosclerosis	0.000149	0.000707	CcSEcCtD
Omeprazole—Diarrhoea—Pravastatin—atherosclerosis	0.000148	0.000702	CcSEcCtD
Omeprazole—Dizziness—Niacin—atherosclerosis	0.000145	0.000689	CcSEcCtD
Omeprazole—Dizziness—Pravastatin—atherosclerosis	0.000143	0.000678	CcSEcCtD
Omeprazole—Nausea—Simvastatin—atherosclerosis	0.000142	0.000674	CcSEcCtD
Omeprazole—Vomiting—Niacin—atherosclerosis	0.00014	0.000662	CcSEcCtD
Omeprazole—Rash—Niacin—atherosclerosis	0.000139	0.000657	CcSEcCtD
Omeprazole—Dermatitis—Niacin—atherosclerosis	0.000138	0.000656	CcSEcCtD
Omeprazole—Headache—Niacin—atherosclerosis	0.000138	0.000653	CcSEcCtD
Omeprazole—Vomiting—Pravastatin—atherosclerosis	0.000138	0.000652	CcSEcCtD
Omeprazole—Rash—Pravastatin—atherosclerosis	0.000136	0.000647	CcSEcCtD
Omeprazole—Dermatitis—Pravastatin—atherosclerosis	0.000136	0.000646	CcSEcCtD
Omeprazole—Headache—Pravastatin—atherosclerosis	0.000135	0.000643	CcSEcCtD
Omeprazole—Nausea—Niacin—atherosclerosis	0.00013	0.000619	CcSEcCtD
Omeprazole—Nausea—Pravastatin—atherosclerosis	0.000128	0.000609	CcSEcCtD
Omeprazole—ATP4B—liver—atherosclerosis	5.77e-05	0.128	CbGeAlD
Omeprazole—ATP4A—connective tissue—atherosclerosis	4.67e-05	0.104	CbGeAlD
Omeprazole—ATP4A—cardiovascular system—atherosclerosis	4.06e-05	0.0903	CbGeAlD
Omeprazole—CYP11A1—connective tissue—atherosclerosis	3.06e-05	0.068	CbGeAlD
Omeprazole—ATP4A—liver—atherosclerosis	2.51e-05	0.0558	CbGeAlD
Omeprazole—CYP11A1—adipose tissue—atherosclerosis	2.35e-05	0.0522	CbGeAlD
Omeprazole—CYP2C18—liver—atherosclerosis	2.07e-05	0.0459	CbGeAlD
Omeprazole—CYP1B1—connective tissue—atherosclerosis	1.86e-05	0.0413	CbGeAlD
Omeprazole—ABCC3—adipose tissue—atherosclerosis	1.82e-05	0.0405	CbGeAlD
Omeprazole—CYP1B1—cardiovascular system—atherosclerosis	1.62e-05	0.0359	CbGeAlD
Omeprazole—CYP1B1—adipose tissue—atherosclerosis	1.43e-05	0.0317	CbGeAlD
Omeprazole—ABCB1—blood vessel—atherosclerosis	1.33e-05	0.0296	CbGeAlD
Omeprazole—ABCC3—liver—atherosclerosis	1.28e-05	0.0284	CbGeAlD
Omeprazole—CYP2C9—cardiovascular system—atherosclerosis	1.1e-05	0.0244	CbGeAlD
Omeprazole—ABCG2—adipose tissue—atherosclerosis	1.06e-05	0.0236	CbGeAlD
Omeprazole—CYP1A1—adipose tissue—atherosclerosis	1.01e-05	0.0224	CbGeAlD
Omeprazole—CYP1B1—liver—atherosclerosis	1e-05	0.0222	CbGeAlD
Omeprazole—CYP2C19—liver—atherosclerosis	8.78e-06	0.0195	CbGeAlD
Omeprazole—CYP2C18—Metabolism—PTGS2—atherosclerosis	8.77e-06	8.54e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.77e-06	8.54e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AGT—atherosclerosis	8.76e-06	8.53e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CETP—atherosclerosis	8.75e-06	8.52e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOA5—atherosclerosis	8.74e-06	8.51e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—FABP4—atherosclerosis	8.73e-06	8.5e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LCAT—atherosclerosis	8.73e-06	8.5e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NAMPT—atherosclerosis	8.6e-06	8.38e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.6e-06	8.37e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SCARB1—atherosclerosis	8.59e-06	8.36e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOE—atherosclerosis	8.59e-06	8.36e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOA4—atherosclerosis	8.57e-06	8.34e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—LIPC—atherosclerosis	8.55e-06	8.33e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—atherosclerosis	8.53e-06	8.31e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.53e-06	8.31e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CG—atherosclerosis	8.52e-06	8.29e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CAV1—atherosclerosis	8.51e-06	8.28e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOC3—atherosclerosis	8.5e-06	8.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.49e-06	8.27e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOA1—atherosclerosis	8.49e-06	8.26e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.48e-06	8.26e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—LIPC—atherosclerosis	8.48e-06	8.25e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—LDLR—atherosclerosis	8.45e-06	8.22e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOC3—atherosclerosis	8.42e-06	8.2e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.42e-06	8.2e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	8.42e-06	8.19e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SCARB1—atherosclerosis	8.38e-06	8.16e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—LDLR—atherosclerosis	8.37e-06	8.15e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.36e-06	8.14e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.32e-06	8.1e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CETP—atherosclerosis	8.25e-06	8.03e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.24e-06	8.03e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.22e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—atherosclerosis	8.22e-06	8e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.2e-06	7.98e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CETP—atherosclerosis	8.18e-06	7.96e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALOX5—atherosclerosis	8.13e-06	7.91e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMGCR—atherosclerosis	8.11e-06	7.9e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.1e-06	7.89e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—INS—atherosclerosis	8.06e-06	7.85e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMGCR—atherosclerosis	7.92e-06	7.71e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.9e-06	7.69e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.83e-06	7.63e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.78e-06	7.58e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.76e-06	7.56e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CG—atherosclerosis	7.75e-06	7.54e-05	CbGpPWpGaD
Omeprazole—CYP2C8—liver—atherosclerosis	7.66e-06	0.017	CbGeAlD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.63e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HMOX1—atherosclerosis	7.58e-06	7.38e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.51e-06	7.31e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—atherosclerosis	7.48e-06	7.28e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMGCR—atherosclerosis	7.46e-06	7.26e-05	CbGpPWpGaD
Omeprazole—ABCG2—liver—atherosclerosis	7.45e-06	0.0165	CbGeAlD
Omeprazole—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.4e-06	7.2e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—atherosclerosis	7.39e-06	7.2e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOA2—atherosclerosis	7.38e-06	7.18e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.38e-06	7.18e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.38e-06	7.18e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.38e-06	7.18e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—INS—atherosclerosis	7.33e-06	7.14e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.32e-06	7.12e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NAMPT—atherosclerosis	7.29e-06	7.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.29e-06	7.09e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOB—atherosclerosis	7.26e-06	7.07e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.25e-06	7.06e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—LIPC—atherosclerosis	7.24e-06	7.05e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.23e-06	7.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOC3—atherosclerosis	7.2e-06	7.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—liver—atherosclerosis	7.17e-06	0.0159	CbGeAlD
Omeprazole—CYP1A2—Metabolism—LDLR—atherosclerosis	7.16e-06	6.97e-05	CbGpPWpGaD
Omeprazole—CYP1A1—liver—atherosclerosis	7.07e-06	0.0157	CbGeAlD
Omeprazole—CYP1B1—Metabolism—NOS3—atherosclerosis	7.07e-06	6.88e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—atherosclerosis	7.06e-06	6.88e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ABCA1—atherosclerosis	7.06e-06	6.87e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LPA—atherosclerosis	7.04e-06	6.85e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CETP—atherosclerosis	6.99e-06	6.8e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.95e-06	6.77e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—LPL—atherosclerosis	6.93e-06	6.75e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BGN—atherosclerosis	6.82e-06	6.64e-05	CbGpPWpGaD
Omeprazole—CYP2C9—liver—atherosclerosis	6.81e-06	0.0151	CbGeAlD
Omeprazole—CYP1A1—Metabolism—GPX1—atherosclerosis	6.76e-06	6.59e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOA5—atherosclerosis	6.75e-06	6.57e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—atherosclerosis	6.72e-06	6.55e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.69e-06	6.52e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.67e-06	6.5e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOB—atherosclerosis	6.66e-06	6.48e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.65e-06	6.47e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.59e-06	6.42e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CD36—atherosclerosis	6.59e-06	6.41e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.52e-06	6.34e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.49e-06	6.32e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.48e-06	6.3e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—atherosclerosis	6.47e-06	6.3e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—atherosclerosis	6.43e-06	6.26e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—LPL—atherosclerosis	6.36e-06	6.19e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMGCR—atherosclerosis	6.32e-06	6.15e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.27e-06	6.11e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—atherosclerosis	6.24e-06	6.08e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.2e-06	6.04e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GPX1—atherosclerosis	6.2e-06	6.04e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARA—atherosclerosis	6.12e-06	5.96e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—atherosclerosis	6.05e-06	5.89e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CD36—atherosclerosis	6.04e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOB—atherosclerosis	5.94e-06	5.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—cardiovascular system—atherosclerosis	5.94e-06	0.0132	CbGeAlD
Omeprazole—CYP1A1—Metabolism—AGT—atherosclerosis	5.93e-06	5.77e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—atherosclerosis	5.88e-06	5.73e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOE—atherosclerosis	5.81e-06	5.66e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOB—atherosclerosis	5.8e-06	5.65e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.78e-06	5.63e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAV1—atherosclerosis	5.76e-06	5.61e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOA1—atherosclerosis	5.74e-06	5.59e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.72e-06	5.57e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.71e-06	5.56e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.7e-06	5.55e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—LPL—atherosclerosis	5.67e-06	5.52e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.66e-06	5.51e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—atherosclerosis	5.64e-06	5.49e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.63e-06	5.49e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.63e-06	5.48e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARA—atherosclerosis	5.61e-06	5.47e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LIPC—atherosclerosis	5.59e-06	5.44e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOC3—atherosclerosis	5.56e-06	5.41e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—LPL—atherosclerosis	5.54e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GPX1—atherosclerosis	5.54e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LDLR—atherosclerosis	5.52e-06	5.38e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOB—atherosclerosis	5.46e-06	5.32e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AGT—atherosclerosis	5.44e-06	5.29e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOB—atherosclerosis	5.42e-06	5.28e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GPX1—atherosclerosis	5.4e-06	5.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CETP—atherosclerosis	5.39e-06	5.25e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CD36—atherosclerosis	5.39e-06	5.25e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOE—atherosclerosis	5.33e-06	5.19e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.32e-06	5.18e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAV1—atherosclerosis	5.28e-06	5.14e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.27e-06	5.13e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOA1—atherosclerosis	5.27e-06	5.13e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CD36—atherosclerosis	5.26e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—atherosclerosis	5.24e-06	5.11e-05	CbGpPWpGaD
Omeprazole—ABCB1—adipose tissue—atherosclerosis	5.24e-06	0.0116	CbGeAlD
Omeprazole—CYP2D6—Metabolism—LPL—atherosclerosis	5.22e-06	5.08e-05	CbGpPWpGaD
Omeprazole—CYP3A4—liver—atherosclerosis	5.19e-06	0.0115	CbGeAlD
Omeprazole—CYP2C9—Metabolism—LPL—atherosclerosis	5.17e-06	5.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.17e-06	5.03e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.11e-06	4.97e-05	CbGpPWpGaD
Omeprazole—CYP2D6—liver—atherosclerosis	5.11e-06	0.0113	CbGeAlD
Omeprazole—CYP11A1—Metabolism—AKT1—atherosclerosis	5.09e-06	4.96e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GPX1—atherosclerosis	5.09e-06	4.96e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—atherosclerosis	5.06e-06	4.93e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GPX1—atherosclerosis	5.05e-06	4.91e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARA—atherosclerosis	5.01e-06	4.88e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—atherosclerosis	4.99e-06	4.85e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—INS—atherosclerosis	4.96e-06	4.83e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CD36—atherosclerosis	4.96e-06	4.83e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CD36—atherosclerosis	4.92e-06	4.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARA—atherosclerosis	4.89e-06	4.76e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.88e-06	4.75e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AGT—atherosclerosis	4.85e-06	4.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.83e-06	4.71e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.81e-06	4.68e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOE—atherosclerosis	4.76e-06	4.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AGT—atherosclerosis	4.74e-06	4.61e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAV1—atherosclerosis	4.71e-06	4.59e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOA1—atherosclerosis	4.7e-06	4.58e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.7e-06	4.57e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.66e-06	4.54e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOE—atherosclerosis	4.64e-06	4.52e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—atherosclerosis	4.64e-06	4.52e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOB—atherosclerosis	4.63e-06	4.51e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARA—atherosclerosis	4.61e-06	4.49e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAV1—atherosclerosis	4.6e-06	4.48e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOA1—atherosclerosis	4.59e-06	4.47e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARA—atherosclerosis	4.57e-06	4.45e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—INS—atherosclerosis	4.55e-06	4.43e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—atherosclerosis	4.55e-06	4.43e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.5e-06	4.38e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AGT—atherosclerosis	4.46e-06	4.35e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AGT—atherosclerosis	4.43e-06	4.31e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—LPL—atherosclerosis	4.42e-06	4.3e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—atherosclerosis	4.41e-06	4.29e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOE—atherosclerosis	4.37e-06	4.26e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—atherosclerosis	4.35e-06	4.24e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.35e-06	4.23e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOE—atherosclerosis	4.34e-06	4.22e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAV1—atherosclerosis	4.33e-06	4.22e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOA1—atherosclerosis	4.32e-06	4.21e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPX1—atherosclerosis	4.31e-06	4.2e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAV1—atherosclerosis	4.3e-06	4.18e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.29e-06	4.18e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—atherosclerosis	4.29e-06	4.18e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOA1—atherosclerosis	4.29e-06	4.17e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CD36—atherosclerosis	4.2e-06	4.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.19e-06	4.08e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—atherosclerosis	4.17e-06	4.06e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—atherosclerosis	4.14e-06	4.03e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—INS—atherosclerosis	4.06e-06	3.96e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—atherosclerosis	4.04e-06	3.94e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—atherosclerosis	3.99e-06	3.89e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—atherosclerosis	3.98e-06	3.88e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.98e-06	3.88e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—INS—atherosclerosis	3.97e-06	3.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.95e-06	3.84e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.91e-06	3.81e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARA—atherosclerosis	3.9e-06	3.8e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—atherosclerosis	3.81e-06	3.71e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AGT—atherosclerosis	3.78e-06	3.68e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—atherosclerosis	3.78e-06	3.68e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—INS—atherosclerosis	3.74e-06	3.64e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.73e-06	3.63e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—atherosclerosis	3.72e-06	3.63e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOE—atherosclerosis	3.71e-06	3.61e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—INS—atherosclerosis	3.7e-06	3.61e-05	CbGpPWpGaD
Omeprazole—ABCB1—liver—atherosclerosis	3.67e-06	0.00816	CbGeAlD
Omeprazole—CYP1A2—Metabolism—CAV1—atherosclerosis	3.67e-06	3.57e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOA1—atherosclerosis	3.66e-06	3.57e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.65e-06	3.55e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—atherosclerosis	3.64e-06	3.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOB—atherosclerosis	3.57e-06	3.48e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—atherosclerosis	3.56e-06	3.47e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—atherosclerosis	3.48e-06	3.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.48e-06	3.38e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—atherosclerosis	3.43e-06	3.34e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LPL—atherosclerosis	3.41e-06	3.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—atherosclerosis	3.4e-06	3.31e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.34e-06	3.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPX1—atherosclerosis	3.33e-06	3.24e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—atherosclerosis	3.28e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.26e-06	3.17e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—atherosclerosis	3.25e-06	3.16e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—atherosclerosis	3.25e-06	3.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CD36—atherosclerosis	3.24e-06	3.16e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—atherosclerosis	3.23e-06	3.14e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—atherosclerosis	3.18e-06	3.1e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—INS—atherosclerosis	3.17e-06	3.08e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.07e-06	2.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARA—atherosclerosis	3.01e-06	2.93e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—atherosclerosis	3e-06	2.92e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.97e-06	2.89e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—atherosclerosis	2.96e-06	2.88e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AGT—atherosclerosis	2.92e-06	2.84e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—atherosclerosis	2.9e-06	2.83e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOE—atherosclerosis	2.86e-06	2.78e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAV1—atherosclerosis	2.83e-06	2.76e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOA1—atherosclerosis	2.83e-06	2.75e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—atherosclerosis	2.78e-06	2.7e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.58e-06	2.51e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.54e-06	2.47e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—atherosclerosis	2.49e-06	2.43e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—INS—atherosclerosis	2.44e-06	2.38e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—atherosclerosis	2.24e-06	2.18e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—atherosclerosis	2.14e-06	2.09e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—atherosclerosis	2e-06	1.95e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.96e-06	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—atherosclerosis	1.83e-06	1.79e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—atherosclerosis	1.64e-06	1.59e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—atherosclerosis	1.6e-06	1.56e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—atherosclerosis	1.51e-06	1.47e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—atherosclerosis	1.49e-06	1.45e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—atherosclerosis	1.28e-06	1.24e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—atherosclerosis	9.85e-07	9.59e-06	CbGpPWpGaD
